Table 2. Patient demographics with and without technical failure.

	Technical Failure n = 114		No Technical Failure n = 1001		P value
Recipient Factors
Female	50	43.9%	504	50.3%	0.189
Age	43.18	± 0.80	43.57	± 0.28	0.653
BMI
<25	46	42.6%	486	50.1%	0.232
25–30	41	38.0%	344	35.4%	0.269
>30	21	19.4%	141	14.5%	0.103
Retransplant	27	23.7%	231	23.1%	0.884
History of Vascular Disease	44	38.6%	421	42.1%	0.478
Dialysis	54	49.1%	447	49.4%	0.944
Smoking History	10	10.3%	116	12.4%	0.530
Donor Factors
Female	42	36.8%	400	40.0%	0.509
Age	34.22	± 1.18	29.31	± 0.40	< 0.001
Race
White	99	92.5%	836	93.5%	0.697
African American	6	5.3%	49	4.9%	0.867
Asian	1	0.9%	9	0.9%	0.980
Cerebrovascular Accident (Stroke)	45	39.8%	303	30.4%	0.040
Alcohol Abuse	15	13.6%	80	8.3%	0.060
Head Trauma or Gunshot Wound	50	44.2%	541	54.2%	0.044
Pancreatitis Donor	3	2.9%	2	0.2%	< 0.001
Drug Abuse	5	5.3%	53	6.3%	0.718
Donation After Cardiac Death	1	0.9%	31	3.1%	0.178
BMI	26.38	± 0.43	24.53	± 0.15	< 0.001
Elevated Recent Creatinine	8	7.5%	21	2.3%	0.002
Elevated Recent Serum Amylase	6	5.7%	31	3.6%	0.209
Preservation Time in Hours	18.52	± 0.45	17.19	± 0.15	0.004
Interval Admit to Brain Death (d)	1.67	± 0.42	2.61	± 0.44	0.126
Pancreas Donor Risk Index	1.61	± 0.06	1.33	± 0.02	< 0.001
Surgical Factors
Bladder Drainage	63	55.8%	647	64.6%	0.063
Allosensitization
Peak PRA Class I	10.81	± 2.74	9.38	± 0.80	0.581
Peak PRA Class II	8.79	± 2.43	8.80	± 0.83	0.995
Peak_Overall_PRA	18.40	± 3.15	19.77	± 1.06	0.682
Zero Mismatches	8	7.1%	57	5.8%	0.591
Peak PRA Greater than 80	13	11.6%	130	13.1%	0.663
Immunosuppression
Thymoglobulin or Atgam	99	88.4%	894	89.8%	0.653
Campath	15	13.4%	199	20.0%	0.094
IL-2R Monoclonal Antibody	62	55.4%	543	54.5%	0.866
Tacrolimus	92	82.1%	825	82.8%	0.646
Cyclosporine	4	3.6%	38	3.8%	0.898
MMF	99	90.8%	900	90.5%	0.968
Prednisone	56	50.5%	560	56.5%	0.227

Count and Percent; or Mean ± S.E.M.